{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:32:57Z","timestamp":1780083177513,"version":"3.54.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":771,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1111\/ajt.15910","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T02:19:14Z","timestamp":1586571554000},"page":"2905-2915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6166-7819","authenticated-orcid":false,"given":"Geertje J.","family":"Dreyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9077-1471","authenticated-orcid":false,"given":"Koen E.","family":"Groeneweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6700-188X","authenticated-orcid":false,"given":"Sebastiaan","family":"Heidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave L.","family":"Roelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"van Pel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Roelofs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkert A.L.","family":"Huurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg M.","family":"Bajema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk Jan A.R.","family":"Moes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem E.","family":"Fibbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans H.J.","family":"Claas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees","family":"van Kooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton J.","family":"Rabelink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan W.","family":"de Fijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9543-567X","authenticated-orcid":false,"given":"Marlies E.J.","family":"Reinders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1111\/ajt.15910_bib1","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.kint.2018.05.018","article-title":"Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015","volume":"94","author":"Coemans","year":"2018","journal-title":"Kidney Int."},{"issue":"3","key":"10.1111\/ajt.15910_bib2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant."},{"issue":"10084","key":"10.1111\/ajt.15910_bib3","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0140-6736(17)31283-7","article-title":"Strategies for long-term preservation of kidney graft function","volume":"389","author":"Wekerle","year":"2017","journal-title":"Lancet."},{"key":"10.1111\/ajt.15910_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/tan.13665","article-title":"Relevance of donor-specific antibody monitoring after kidney transplantation: findings from the collaborative transplant study and the Heidelberg transplant center","volume":"94","author":"S\u00fcsal","year":"2019","journal-title":"HLA."},{"issue":"1","key":"10.1111\/ajt.15910_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/MOT.0000000000000032","article-title":"Mesenchymal stromal cells to prevent fibrosis in kidney transplantation","volume":"19","author":"Reinders","year":"2014","journal-title":"Curr Opin Organ Transplant."},{"issue":"1","key":"10.1111\/ajt.15910_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MOT.0000000000000035","article-title":"Mesenchymal stromal cells to promote kidney transplantation tolerance","volume":"19","author":"Casiraghi","year":"2014","journal-title":"Curr Opin Organ Transplant."},{"issue":"9","key":"10.1111\/ajt.15910_bib7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/tri.12132","article-title":"Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation","volume":"26","author":"Perico","year":"2013","journal-title":"Transpl Int."},{"issue":"2","key":"10.1111\/ajt.15910_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5966\/sctm.2012-0114","article-title":"Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study","volume":"2","author":"Reinders","year":"2013","journal-title":"Stem Cells Transl Med."},{"issue":"1","key":"10.1111\/ajt.15910_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nep.12338","article-title":"Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation: a pilot study","volume":"20","author":"Mudrabettu","year":"2015","journal-title":"Nephrology."},{"issue":"3","key":"10.1111\/ajt.15910_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mad.2007.12.002","article-title":"Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies","volume":"129","author":"Stolzing","year":"2008","journal-title":"Mech Ageing Dev."},{"key":"10.1111\/ajt.15910_bib11","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3389\/fimmu.2019.01244","article-title":"Dissecting allo-sensitization after local administration of human allogeneic adipose mesenchymal stem cells in perianal fistulas of Crohn\u2019s disease patients","volume":"10","author":"Avivar-Valderas","year":"2019","journal-title":"Front Immunol."},{"issue":"1","key":"10.1111\/ajt.15910_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/TP.0b013e3182754c53","article-title":"Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study","volume":"95","author":"Peng","year":"2013","journal-title":"Transplantation."},{"issue":"3","key":"10.1111\/ajt.15910_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.kint.2018.08.046","article-title":"Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study","volume":"95","author":"Erpicum","year":"2019","journal-title":"Kidney Int."},{"issue":"1","key":"10.1111\/ajt.15910_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MOT.0000000000000043","article-title":"Autologous and allogeneic mesenchymal stem cells in organ transplantation: what do we know about their safety and efficacy?","volume":"19","author":"Alagesan","year":"2014","journal-title":"Current Opinion in Organ Transplantation."},{"key":"10.1111\/ajt.15910_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12967-015-0700-0","article-title":"Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study","volume":"13","author":"Reinders","year":"2015","journal-title":"J Transl Med."},{"issue":"1","key":"10.1111\/ajt.15910_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2047-1440-2-17","article-title":"Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study","volume":"2","author":"Streitz","year":"2013","journal-title":"Transplant Res."},{"issue":"21","key":"10.1111\/ajt.15910_bib17","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1089\/scd.2013.0193","article-title":"Mesenchymal stem cells induce an inflammatory response after intravenous infusion","volume":"22","author":"Hoogduijn","year":"2013","journal-title":"Stem Cells Dev."},{"issue":"1\u20132","key":"10.1111\/ajt.15910_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jchromb.2004.11.046","article-title":"Development and validation of an HPLC-UV method for determination of iohexol in human plasma","volume":"816","author":"Soman","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"issue":"11","key":"10.1111\/ajt.15910_bib19","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 reference guide to the Banff classification of renal allograft pathology","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation."},{"issue":"6","key":"10.1111\/ajt.15910_bib20","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/01.ASN.0000066143.02832.5E","article-title":"Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function","volume":"14","author":"Grimm","year":"2003","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"10.1111\/ajt.15910_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00228-015-1963-3","article-title":"Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients","volume":"72","author":"Moes","year":"2016","journal-title":"Eur J Clin Pharmacol."},{"issue":"1","key":"10.1111\/ajt.15910_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0198-8859(93)90143-O","article-title":"Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant","volume":"37","author":"Verduyn","year":"1993","journal-title":"Hum Immunol."},{"issue":"2","key":"10.1111\/ajt.15910_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2215\/CJN.04950610","article-title":"Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility","volume":"6","author":"Perico","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1111\/ajt.15910_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12967-014-0331-x","article-title":"Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients","volume":"12","author":"Reinders","year":"2014","journal-title":"J Transl Med."},{"issue":"9955","key":"10.1111\/ajt.15910_bib25","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0140-6736(14)61095-3","article-title":"Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial","volume":"384","author":"Haynes","year":"2014","journal-title":"Lancet (London, UK)."},{"key":"10.1111\/ajt.15910_bib26","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3389\/fimmu.2018.01359","article-title":"Long-term clinical and immunological profile of kidney transplant patients given mesenchymal stromal cell immunotherapy","volume":"9","author":"Perico","year":"2018","journal-title":"Front Immunol."},{"issue":"5","key":"10.1111\/ajt.15910_bib27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/1744666X.2015.1029458","article-title":"Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review","volume":"11","author":"Luk","year":"2015","journal-title":"Expert Rev Clin Immunol."},{"issue":"5","key":"10.1111\/ajt.15910_bib28","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.exphem.2009.01.005","article-title":"Mesenchymal stem cells suppress B-cell terminal differentiation","volume":"37","author":"Asari","year":"2009","journal-title":"Exp Hematol."},{"issue":"5","key":"10.1111\/ajt.15910_bib29","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.4049\/jimmunol.1203261","article-title":"In kidney transplant patients, alemtuzumab but not basiliximab\/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development","volume":"191","author":"Todeschini","year":"2013","journal-title":"J Immunol."},{"issue":"25","key":"10.1111\/ajt.15910_bib30","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15910","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15910","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15910","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522224800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522224800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:29:31Z","timestamp":1761629371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522224800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1600613522224800"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15910","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}